雜志介紹

Ophthalmology And Therapy雜志介紹

《Ophthalmology And Therapy》是一本以English為主的開(kāi)放獲取國(guó)際優(yōu)秀期刊，中文名稱眼科和治療，本刊主要出版、報(bào)道醫(yī)學(xué)-OPHTHALMOLOGY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為2.6，最新CiteScore 指數(shù)為4.2。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• Nonsurgical Management of Severe Viral Keratitis with Hypopyon and Retrocorneal Plaques: A Case Series

  Author: Yang, Zhen; Yu, Shuo; Zhang, Chun; Agrawal, Rupesh; Feng, Yun

• The Double-Deck Viscoelastic Technique: a Novel Surgical Technique to Protect the Corneal Endothelium in Penetrating Keratoplasty of Aphakic Silicone Oil-Dependent Eyes after Severe Ocular Injury

  Author: Cen, Yujie; Zhang, Mingzhou; Lu, Yao; Feng, Yun

• Determination of Vascular Endothelial Growth Factor-B Concentrations in Aqueous Humor and Plasma of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy Patients Before and After Anti-VEGF Therapy

  Author: Zhou, Huiying; Zhao, Xinyu; Wang, Shuran; Chen, Youxin

• Clinical Feasibility and Safety of Scleral Collagen Cross-Linking by Riboflavin and Ultraviolet A in Pathological Myopia Blindness: A Pilot Study

  Author: Li, Yu; Qi, Yue; Sun, Mingshen; Zhai, Changbin; Wei, Wenbin; Zhang, Fengju

英文介紹

Ophthalmology And Therapy雜志英文介紹

Ophthalmology And Therapy is an open access, peer-reviewed (single-blind), fast-publishing international journal. The scope of the journal is broad and will consider all scientifically sound research, from preclinical, clinical (all stages), observational, real-world and health outcome studies, around the use of ophthalmic therapies, devices and surgical techniques.

The journal is of interest to a broad range of pharmaceutical and healthcare professionals and publishes short newsletters such as original studies, reviews, case reports/series, trial protocols, and reviews and editorials. Ophthalmology and treatment will consider all scientifically sound studies, whether positive, confirmed or negative data. Submissions are welcome regardless of whether they reach an international and/or country-specific audience, which is crucial when researchers are trying to target more specific patient groups. This inclusive approach allows the journal to assist in disseminating high-quality research, which may be considered of insufficient interest by other journals.